Warnings of faulty AI, and experimental CRISPR treatments

[ad_1]

Meredith Broussard is unusually well placed to debunk the hype around AI. She is a data scientist and associate professor at New York University, and has been a leading researcher in the field of algorithmic bias for years.

And while her own work has left her buried in math problems, she’s spent the last few years thinking about problems that math can’t solve. Broussard is passionate about applying artificial intelligence to social problems in inappropriate and harmful ways—especially when race, gender, and ability are not taken into account.

Broussard spoke with our high-tech policy reporter, Tate Ryan-Moseley, about the challenges in police use of technology, the limits of “AI equity,” and the potential solutions AI is seeing for some of the challenges. Read the full story.

More than 200 people have been treated with experimental CRISPR treatments

Jessica Hamzelu, senior biotech reporter at MIT Technology Review, has been grappling with an emotional and ethical dilemma for scientists, ethicists and patient groups.

At the Third International Conference on Human Genome Editing in London, they debated whether, when and how we should use gene-editing tools to alter the human genome.

There is much to be excited about. In the decades since scientists discovered they could use CRISPR to edit a cell’s genome, the technology has been used to save some and transform others.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

sixteen − 13 =